Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment
Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment
The principal objective of the study is the evaluation of the role of Human Papilloma Virus (HPV) in plantar warts (prevalence, genotype), resistant or not, treated or not, cured or not. This epidemiological study is an ancillary study of the prospective, randomized controlled, clinical study VRAIE (sponsor: APHP) comparing 5 usual strategies in the management of plantar warts.
Inclusion Criteria:
Male or female patient aged 18 years or more.
Clinical evaluation
Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm, whether previously treated or not
In treated patients, all potentially active treatment on warts since at least one month should be stopped.
Effective contraception for women of childbearing age
Immunocompetent patients
Patient with one or more warts on soles and board feet.
Patient affiliated to the French social security.viral
Exclusion Criteria: